Metabolic profiling distinguishes three subtypes of Alzheimer's disease

Aging

Volumn 7, Issue 8, 2015, Pages 595-600

  Bredesen, Dale E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Biomarkers; Cognition; Dementia; Dyscalculia; Inflammation; Insulin resistance; Neurodegeneration

Indexed keywords

ZINC;

AGED; ALZHEIMER DISEASE; CASE REPORT; CLASSIFICATION; DEFICIENCY; FEMALE; HUMAN; MALE; METABOLISM; METABOLOME; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; FEMALE; HUMANS; MALE; METABOLOME; MIDDLE AGED; ZINC;

EID: 84941196789     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100801     Document Type: Article

References (19)

1. James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K and Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014; 82:1045-1050.
2. Sasanka Chakrabarti, Vineet Kumar Khemka, Anindita Banerjee, Gargi Chatterjee, Anirban Ganguly, Atanu Biswas. Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment. Aging and Disease. 2015; 6:282-299.
3. Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Paajanen T, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015; 385:2255-2263.
4. Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL and Kapogiannis D. Altered lysosomal proteins in neuralderived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015; 85:40-47.
5. Bredesen DE. Reversal of cognitive decline: A novel therapeutic program. Aging Journal. 2014; 6:1-11.
6. Heppner FL, RansohoffRM and Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015; 16:358-372.
7. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006; 12:1005-1015.
8. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K and Salminen A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013; 25:1939-1948.
9. Theendakara V, Patent A, Peters Libeu CA, Philpot B, Flores S, Descamps O, Poksay KS, Zhang Q, Cailing G, Hart M, John V, Rao RV and Bredesen DE. Neuroprotective Sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci U S A. 2013; 110:18303-18308.
10. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45:1452-1458.
11. Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J and Teplow DB. 1alpha,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer's disease patients. J Alzheimers Dis. 2013; 34:155-170.
12. Kurakin A and Bredesen DE. Dynamic self-guiding analysis of Alzheimer's disease. Oncotarget. 2015; 6:14092-14122.
13. Rocca WA and Henderson VW. Is there a link between gynecologic surgeries and Alzheimer disease? Neurology. 2014; 82:196-197.
14. Zhang CE, Tian Q, Wei W, Peng JH, Liu GP, Zhou XW, Wang Q, Wang DW and Wang JZ. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging. 2008; 29:1654-1665.
15. Moustafa AA, Hewedi DH, Eissa AM, Frydecka D and Misiak B. Homocysteine levels in schizophrenia and affective disordersfocus on cognition. Frontiers in behavioral neuroscience. 2014; 8:343.
16. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K and Hodges JR. Focal cortical presentations of Alzheimer's disease. Brain. 2007; 130:2636-2645.
17. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2005; 7:221-232; discussion 255-262.
18. McCall KA, Huang CC, Fierke CA. Function and Mechanism of Zinc Metalloenzymes. The Journal of Nutrition. 2000; 1427S-1446S.
19. Brewer GJ and Kaur S. Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease. International journal of Alzheimer's disease. 2013; 2013:586365.